secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unity Biotechnology, Inc. (—)
CIK:        0001463361
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0000950170-25-088503
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Unity Bio receives Nasdaq deficiency notice for bid price and equity; shares below $1.00
--------------------------------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive business days; 180-day cure period until Dec 15, 2025.
- Previously (Mar 2025) notified for equity below $10M minimum for Nasdaq Global Select; compliance plan submitted.
- Company applied to transfer to Nasdaq Capital Market on June 9, 2025.
- Failure to regain compliance may result in delisting; no assurance of cure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1463361/000095017025088503/0000950170-25-088503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1463361/000095017025088503/ubx-20250618.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-088503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer